Molecular mechanisms involved in the diverse actions of ghrelin
Satou, M.
Seikagaku. Journal of Japanese Biochemical Society 85(7): 557-561
2013
ISSN/ISBN: 0037-1017 PMID: 23980470 Document Number: 665699
Document emailed within 1 workday
Related Documents
Kushiku, K.; Ohba, M.; Mikagi, T.; Nuki, S.; Araki, Y.; Furukawa, T. 1989: Cardiovascular actions of buflomedil and possible mechanisms involved Arzneimittel-Forschung 39(6): 670-677Adcock, I.M.; Ito, K. 2000: Molecular mechanisms of corticosteroid actions Monaldi Archives for Chest Disease 55(3): 256-266
Toyota, M.; Suzuki, H.; Nishizaka, T.; Sato, A.; Yamashita, T. 2010: Molecular mechanisms involved in epigenetic alterations in cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(9): 1650-1653
Hayward, C.M.; Griffin, G.E. 1994: Antibiotic resistance: the current position and the molecular mechanisms involved British Journal of Hospital Medicine 52(9): 473-478
Zasukhina, G.D. 1987: Molecular-genetic mechanisms of the pathogenesis of human diseases related to disorders of processes involved in the repair of DNA damage Arkhiv Patologii 49(1): 3-9
Skoczylas, A.; Wiecek, A. 2006: Ghrelin, a new hormone involved not only in the regulation of appetite Wiadomosci Lekarskie 59(9-10): 697-701
Tonini, G.P. 1988: Molecular mechanisms involved in DNA repair, in gene rearrangement and in gene amplification may be considered as an integrated system in maintaining cellular homeostasis and cell survival Anticancer Research 8(5a): 881-884
Wagner, A.C.; Williams, J.A. 1994: Low molecular weight GTP-binding proteins: molecular switches regulating diverse cellular functions American Journal of Physiology 266(1 Pt 1): G1-14
Lau, J.Y. 1998: Mechanisms of hepatic toxicity. IV. Pathogenetic mechanisms involved in hepatitis C virus-inducedliver diseases American Journal of Physiology 275(6): G1217-G1220
Seppälä, M.; Taylor, R.N.; Koistinen, H.; Koistinen, R.; Milgrom, E. 2002: Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation Endocrine Reviews 23(4): 401-430
Li, J.; Yi, S.-Q.; Terayama, H.; Naito, M.; Hirai, S.; Qu, N.; Wang, H.-X.; Yi, N.; Ozaki, N.; Itoh, M. 2010: Distribution of ghrelin-producing cells in stomach and the effects of ghrelin administration in the house musk shrew (Suncus murinus) Neuro Endocrinology Letters 31(3): 406-412
Liu, W.; Yue, H.; Zhang, J.; Pu, J.; Yu, Q. 2014: Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome Chinese Medical Journal 127(5): 850-855
Kimura, S. 1983: Mechanism of actions involved in improved effects of calcium channel blockers on ischemic myocardial conduction delay Hokkaido Journal of Medical Science 58(5): 490-501
Sheikh, S.P.; Carisen, J.; Hansen, P.R.; Haunsø, S. 1997: Molecular biology and cardiology. Molecular mechanisms in heart failure Ugeskrift for Laeger 159(17): 2523-2528
Krieglstein, J. 1997: Mechanisms of neuroprotective drug actions Clinical Neuroscience 4(4): 184-193
Kuroki, T.; Kato, R. 1986: On the mechanisms of actions of tumor promoters Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 2): 754-757
Rothwell, N.J. 1990: Mechanisms of the pyrogenic actions of cytokines European Cytokine Network 1(4): 211-213
Burks, T.F. 1976: Antiadrenergic actions of metiamide in cat thermoregulatory mechanisms Proceedings of the Western Pharmacology Society 19: 75-78
Fischer, H.D.; Schmidt, J.; Wustmann, C. 1984: On some mechanisms of antihypoxic actions of nootropic drugs Biomedica Biochimica Acta 43(4): 541-543
Nowak, G.; Szewczyk, B. 2002: Mechanisms contributing to antidepressant zinc actions Polish Journal of Pharmacology 54(6): 587-592